<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04933253</url>
  </required_header>
  <id_info>
    <org_study_id>HM20021183</org_study_id>
    <nct_id>NCT04933253</nct_id>
  </id_info>
  <brief_title>Mediastinal Temperature and Post-operative Bleeding</brief_title>
  <official_title>Mediastinal Temperature and Post-operative Bleeding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Virginia Commonwealth University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate how chest temperature relates to blood loss and blood clotting.&#xD;
      Researchers will use infra-red thermometers to measure the temperature of the chest at the&#xD;
      end of surgery see if this relates to the amount of blood collected from the surgical drains.&#xD;
      In addition, researchers will test if warm irrigation of the chest increases the temperature&#xD;
      of the chest and if this impacts blood loss.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Low body temperature during surgery, defined as a temperature below 34 Â°C, occurs commonly in&#xD;
      patients undergoing cardiac surgery due to the bypass machine and an open chest. Low body&#xD;
      temperature has been associated with blood loss, but the relevant published data are&#xD;
      inconclusive. Nevertheless, evidence suggests that blood loss during and after surgery are&#xD;
      higher in low body temperature patients than in the normal body temperature patients. In&#xD;
      addition, low body temperature can impair blood clotting. The clinical significance of this&#xD;
      is high as it is well established that blood transfusion increases mortality after surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">August 2025</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Chest temperature</measure>
    <time_frame>At the end of surgery, up to 5 hours</time_frame>
    <description>We will use infra-red thermometers to measure the temperature of the chest at the end of surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Amount of blood loss</measure>
    <time_frame>24 hours after the end of surgery</time_frame>
    <description>amount of blood drained into the cell-saving device or collection canisters from the chest drains that are left in all patients after surgery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Blood Loss, Surgical</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>this cohort will receive 2 L of warm 37celsius saline irrigation of the mediastinum prior to closure of the chest</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>this cohort will receive the normal standard of care as established by the primary surgeon</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Saline irrigation</intervention_name>
    <description>Mediastinal irrigation with 2 L of 37 degree Celsius saline prior to chest closure</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing open cardiac surgery at VCU&#xD;
&#xD;
          -  Age18 to 80 years&#xD;
&#xD;
          -  American Society of Anesthesiologists Physical Status 1-3&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of excessive bleeding&#xD;
&#xD;
          -  partial thromboplastin time &gt; 35 s&#xD;
&#xD;
          -  prothrombin time &gt; 35 s&#xD;
&#xD;
          -  fibrinogen &lt; 200 mg/dL&#xD;
&#xD;
          -  platelet count &lt; 100,000/L&#xD;
&#xD;
          -  history of infection and fever within 4 weeks before surgery&#xD;
&#xD;
          -  use of steroid or immunosuppressant within 4 weeks before surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arturo Cardounel, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Commonwealth University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arturo Cardounel, M.D.</last_name>
    <phone>804-628-2998</phone>
    <email>arturo.cardounel@vcuhealth.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 14, 2021</study_first_submitted>
  <study_first_submitted_qc>June 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2021</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Blood Loss, Surgical</mesh_term>
    <mesh_term>Postoperative Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

